Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer

NCT04224922 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Carboplatinum
DRUG: Epirubicin
DRUG: Cyclophosphamide

Sponsor

Universitair Ziekenhuis Brussel

Collaborators

[object Object]